Senior Quantum Scientist

Join Us in the Fight Against Alzheimer's Disease Psychosis! Are you or someone you care about dealing with Alzheimer’s Disease? We encourage you to take part in vital clinical trials focused on enhancing research and treatment options for this condition. We are seeking patient volunteers to help evaluate the effectiveness of a new medication for this purpose. The medication will be provided at no cost to you or your insurance. Participants will receive compensation for their time and travel, and if you refer a qualifying friend, you will earn a $100 bonus. Call 480-716-4590 Now! Or Apply Here To qualify, you must: ● Be a male or female, 55 - 95 years of age ● Be diagnosed with Alzheimer's Disease or probable Alzheimer's Disease ● Have a prior history of psychotic symptoms for at least 2 months prior to Screening WHY PARTICIPATE? ●Compensation: Get compensated up to $3,400, with no cost to you or your insurance! ●Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being. ●No-cost study medications: Study medications are given at no charge. Check out our other studies! ● Multiple Sclerosis ● Obstructive Sleep Apnea ● Excessive Sleepiness Due to Shift Work ● Narcolepsy and Idiopathic Hypersomnia ● General Anxiety Disorder ● Asthma Treatment ● Cardiovascular Risk Factor Study ● Future Studies AND MANY MORE! Chandler Clinical Trials (CCT) Contact us today at 480-716-4590 or visit us at https://chandlertrials.com/ for more details! Advancing Medicine Through Research!

The Company Surrozen is a biotechnology company pioneering targeted therapeutics that selectively activate the Wnt Pathway for tissue repair and regeneration.  Surrozen is focusing its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. The Company recently completed a private placement consisting of two tranches in aggregate up to $175 million in gross proceeds to fund multiple ophthalmology programs through initial Phase 1 safety, tolerability and efficacy studies. The Company expects to file an IND in 2026.   Modulation of Wnt signaling has the potential to be relevant in a broad range of highly prevalent eye diseases including “wet” and “dry” Age Related Macular Degeneration (AMD), diabetic retinopathy, Fuchs’ endothelial corneal dystrophy (FECD), and non-infectious uveitis as well as certain rare eye diseases like retinitis pigmentosa, Stargardt’s and Familial Exudative Vitreoretinopathy (FEVR). The two lead candidates for the treatment of retinopathies include SZN-8141 (Fzd4/VEGF) and SZN-8143 (Fzd4/VEGF/IL-6).   SZN-8141 combines Frizzled 4 (Fzd4) agonism and Vascular Endothelial Growth Factor (VEGF) antagonism which has the potential to provide benefits over treatment with single agents for Diabetic Macular Edema (DME) and neovascular Age Related Macular Degeneration (wet AMD).    SZN-8143 combines Fzd4 agonism, VEGF antagonism, and interleukin-6 (IL-6) antagonism which may have benefits over single agents for treatment of DME/wet AMD/uveitic macular edema (UME).    Job Overview We are seeking a highly motivated Scientist, for a full-time position to support drug development programs in the ophthalmology space. You will be involved in establishing in vitro model systems and cell-based assays for evaluating antibody drug efficacy and mode of action. You will also be involved in designing and executing in vivo MOA studies in various animal eye disease models, leveraging state-of-the-art technologies and techniques. The successful candidate will have a PhD degree in Biochemistry/Cell and Molecular Biology/Developmental Biology/Neurobiology and, ideally, with postdoctoral training in eye biology or ophthalmology related fields. The ideal candidate should have a good track record of peer-reviewed publications, excellent scientific vision, critical thinking, technical versatility and productivity. This position offers an exciting opportunity to contribute to many of Surrozen’s preclinical and clinical programs to potentially transform the treatment options of severe eye diseases, including DME, nAMD and dAMD.  Pay Range: $110,435 - $198,420 Primary Duties:  Design and execute experiments: Design and perform in vitro (cell-based) and sometimes in vivo (animal-based) studies to explore disease mechanisms and test new molecules.  Discover and validate targets: Identify potential new targets for drug intervention and validate their role in the disease process through advanced molecular and cellular biology techniques.  Develop and run assays: Develop and optimize high-throughput screening assays to test and rank large pools of drug candidates.  Analyze and interpret data: Systematically analyze complex experimental data, critically evaluate and interpret data, draw conclusions, and present findings to project teams to guide drug development decisions.  Collaborate across functions: Work closely with cross-functional teams, including protein biochemists, pharmacologists, and data scientists, to drive discovery programs.  Manage external partnerships: Engage with and oversee work conducted by contract research organizations (CROs) for specialized tasks.  Engage with key opinion leaders (KOLs): Develop and maintain communication with a network of scientific advisors and consultants.  Contribute to scientific strategy: Stay current with scientific literature and contribute to setting the strategic direction for discovery efforts in the ophthalmology therapeutics field.  Presentation and publication: Publish data and research discoveries as conference abstracts, patents and peer-reviewed papers as guided by Surrozen publication strategy    Requirements Ph.D. in Biochemistry, Cell Biology, Molecular Biology, Developmental Biology, Neurobiology or related fields  Minimum 2+ year experience in eye research with track record of peer reviewed publications  Demonstrated strong wet-lab molecular and cell biology techniques, e.g. molecular cloning, qPCR, siRNA, Crispr-Cas9 gene editing, IF/IHC, ISH/FISH, FACS, ELISA, Western blotting, protein IP, mammalian cell/organoid culture, reporter/enzymatic cell-based assays, animal tissue manipulation and primary cell isolation  Experience with fluorescence confocal microscopy and imaging analysis is a must  Familiar with in vitro, ex vivo and animal retinal disease models  Experience with high-throughput sequencing, single-cell sequencing, spatial transcriptomics, proteomic workflow, R programing and data analysis is a plus  Excellent organizational and communication skills  Ability to work in fast paced environment and make contributions to multiple projects  Experience in coaching junior scientists or students  Strong interpersonal skills and a team player committed to success and getting the job done well in a highly dynamic environment  Attention to detail, self-motivated    Benefits We offer a dynamic working environment and a collaborative, passionate team Excellent benefits, including competitive employer contributions Stock Options Paid vacation, sick time and holidays Shuttle service to/from Caltrain, BART and the SSF Ferry State of the art research facility complete with bowling alley and onsite gym amenities available through The Cove

PARTICIPANTS NEEDED FOR A RESEARCH STUDY AT INDIANA UNIVERSITY SCHOOL OF MEDICINE (Psychiatry Department) We are conducting a 12-week clinical trial to see if the medication Guanfacine XR (an FDA approved drug used to treat ADHD) vs. a placebo (sugar pill) can help reduce alcohol craving and drinking. A potential subject: • Is 18 years or older • Struggles with alcohol use • Is Male or Female Click the link to complete the eligibility survey: https://redcap.link/axzyv6om Or call one of our Research Assistants @ 317-274-0851 or 317-274-0837 If Eligible, your participation will include: • Stop by for an in person visit to complete a physical & answer some questionnaires • Be randomly assigned to either guanfacine or placebo • Completing daily tasks (short surveys, urine screening, and medication intake) remotely • Attending 2 brief remote visits each week for 12 weeks In appreciation of your time you can receive up to $1,300 (based on participation) Principle Investigator: Helen Fox Ph.D. IRB #24432

Analyst in the Holt Group: Washington D.C. Intellectual Property Team Ready to make your mark in the heart of D.C.? Answer the city’s infamous "What do you do?" question by stepping into a career with purpose at Econ One. Join us as an Analyst in the Holt Group: Washington D.C. Intellectual Property Team. At the Holt Group, precision is our mission; meticulous attention to detail unites us. Your journey starts with a comprehensive onboarding, preparing you to skillfully craft drafts of quantitative analyses, presentations, and reports. Additionally, you’ll conduct financial, market, legal, and product research, and learn the art of financial modeling. If you excel (and we hope you love Excel) in critical thinking and clarifying complexity, this role lays the foundation for a rewarding career. Efficiency meets collaboration in our carefully crafted approach to litigation consulting. You'll shine as an individual and thrive as part of a dedicated team, all in service to our valued clients. Our diligent investment in streamlined procedures ensures that when you clock out, the majority of your evenings and weekends are yours to enjoy your unique passions. Embrace the modern fusion of work environments: part remote, part in our downtown D.C. office. Imagine diving into challenging work from the comfort of your own space, then coming together in an office setting just steps away from the Metro and sharing lunches from local favorites like Roti and Taylor Gourmet. Long-term isn't just a buzzword – it's our way of life. With our longstanding clients representing over 180+ diverse industries and our work spanning patent, trademark, trade secret, copyright, antitrust, class action, breach of contract, and more, your intellectual curiosity will be nourished daily. Our team flourishes through advancement opportunities and tailored professional development, backed by unwavering support. It's all anchored in integrity, teamwork, and open communication – our all-for-one approach. Our Managing Director, Krista Holt, is an influential expert. She's the go-to expert for patent, trademark, trade secret, copyright, and more. Her journey isn't a mere résumé; it's a saga of innovation, dedication, and unyielding pursuit of excellence. Ms. Holt helps to set industry standards. Dive into Krista Holt's realm through the links below to learn more. https://www.econone.com/staff-member/krista-holt/ https://www.siouxfallslive.com/news/sioux-falls/sioux-steel-awarded-12m-in-patent-infringement-case-against-illinois-based-competitor (Our Client Sioux Steel) Requirements BS in Commerce, Business, Accounting, Finance, or Economics GPA of 3.4 or higher Commitment to integrity, excellence, and teamwork (the rewarding kind, not the group work kind where you have to carry everyone else so you can get an A) Benefits Intrigued? Econ One is renowned for offering a competitive salary and unbeatable benefits, including healthcare, dental, and 100% employer-paid life and disability insurance. Our team mirrors Econ One's unwavering commitment to exceptional quality, integrity, and value – in the work we deliver to clients and the experience we provide our team.

Food Scientist – Gummy Formulation We are developing a gummy to support women’s health and need a food scientist who can move fast and deliver results. What you will do: • Formulate and refine the gummy recipe for flavor, texture, and stability • Select and test ingredients including gelatin, pectin, sweeteners, acids, and botanicals • Optimize texture and mouthfeel with your knowledge of gelling agents and sweeteners • Ensure compliance, safety, shelf life, and nutritional claims What we are looking for: • Experience in food formulation, especially functional or dietary gummies • Strong background in food chemistry and biology • Ability to work quickly and creatively in a lab setting • Understanding of regulatory and food safety standards Why join us: Be the lead formulator on a high demand women’s health product and help take it from concept to launch. Contract or project based, remote or lab based, immediate start.

Full details are available at: https://www.imachines.com/imi-ai-ml-fellowships-2025-2026-high-risk-research 12 places will be opened for the 2025-2026 term, with a duration of 6 or 12 months at the applicant's option. The intent of the fellowship is to focus on high risk research: ambitious projects that may not produce results, but will have lasting impact if they work. We believe that publication in AI/ML has become overly biased towards short-term and iterative results, despite major gaps in our understanding of how to build optimal models. The goal of these fellowships is to give awardees uninterrupted time to focus on harder open problems, with adequate compute, talented peers, and weekly 1:1 mentorship from senior researchers but without chasing specific metrics. You will be expected to spend about 80% of your time on your own research, and up to 20% of your time either assisting other fellows or participating in wider research programs at IMI. We focus largely on applied research and its applications to online security problems, but often publish and support frontier research aligned with our broader interests. Serving hundreds of millions of people gives us a unique perspective as to what works at scale. Eligibility: prior fellows and research staff have come from disparate backgrounds, including early career researchers previously at MSR, FAIR, Mila, MPI, etc. and self taught mid career engineers transitioning into research. We do not discriminate on the basis of pedigree or age. If you have done interesting work, that is enough. You may reside anywhere in the world, excluding sanctioned jurisdictions. This will be a remote fellowship. Deliverables: we do not have hard targets, but generally try to get 1-2 papers with code done in a year, targeting NeurIPS, ICML, ICLR, etc. At the end of your fellowship, if the threshold for publication at a conference or in a journal is unmet we will expect a final report, which may be published as a blog post. Applying: send a brief bio / CV link via this page. Include 1) the topic you are interested in working on, 2) a few lines on any relevant prior work you've done, 3) your github / scholar / x links, 4) your desired start date, duration, and other obligations (if any) during that period, and 5) a brief analysis of one of the projects outlined below. Each project intentionally includes some gaps or glosses. List the ones you see, and how you'd solve them. Alternatively, if you dislike the projects outlined under a particular topic, write up your own idea and why it is more promising, along with your estimate of time and compute required. Deadline: Admitting fellows in two cohorts. Deadlines for consideration: Oct 1 25, Feb 1 26. 3 week decision period. Rolling thereafter. Compensation: competitive location-adjusted stipend, conference and travel support for conferences with accepted papers. Selection criteria: novelty and importance, clarity of approach, feasibility given time/compute, alignment with topics. Panel review and one interview. Selection will be based solely on merit. IMI is an equal opportunity employer, and does not discriminate on the basis of age, disability, sex, orientation, race, religion or belief. We promote equality of opportunity for all, and welcome applications from anyone with talent, skills and potential.